GCC4002
Phase 3- Indications
- Pancreatic Cancer, Liver cancer
Company intelligence / Profile preview
GCCL specializes in providing GCLP-certified clinical trial sample analysis services across Asia-Pacific. The company has recently expanded its R&D division to proactively develop pharmacokinetic and biomarker assay methods for biosimilars of blockbuster drugs like Keytruda and Yervoy. It offers advanced analytical solutions including ELISA and digital droplet PCR for cell/gene therapy trials. Its expertise enables rapid support of multinational trials with high-quality data integrity.[1][2][7]
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GCCL.